Cargando…

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice

Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental condition that currently has no specific drug treatment. Building upon the demonstrated therapeutic effects on spatial memory of bryostat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cogram, Patricia, Alkon, Daniel L., Crockford, David, Deacon, Robert M. J., Hurley, Michael J., Altimiras, Francisco, Sun, Miao-Kun, Tranfaglia, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581799/ https://www.ncbi.nlm.nih.gov/pubmed/33093534 http://dx.doi.org/10.1038/s41598-020-74848-6

Ejemplares similares

Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
por: Altimiras, Francisco, et al.
Publicado: (2021)

Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)
por: Gurney, Mark E., et al.
Publicado: (2017)

Advanced Alzheimer’s Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial
por: Alkon, Daniel L., et al.
Publicado: (2023)

The inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypes
por: Cogram, Patricia, et al.
Publicado: (2022)

Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy
por: Reyes, Samantha T., et al.
Publicado: (2021)

Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome
por: Cogram, Patricia, et al.
Publicado: (2019)

Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer’s Disease Phase IIa and Expanded Access Trials
por: Nelson, Thomas J., et al.
Publicado: (2017)

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease
por: Farlow, Martin R., et al.
Publicado: (2019)

Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer’s Disease in the Absence of Memantine(1)
por: Thompson, Richard E., et al.
Publicado: (2022)

Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes
por: Stepniak, Beata, et al.
Publicado: (2015)

Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010)

Beneficial effect of interventional exercise on autistic Fragile X syndrome
por: Lee, Seunghoon, et al.
Publicado: (2017)

Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease
por: Altimiras, Francisco, et al.
Publicado: (2017)

Bryostatin analog: improving on Nature's design
por: Boger, Dale
Publicado: (2012)

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice
por: Westmark, Cara J., et al.
Publicado: (2011)

Adult Restoration of Shank3 Expression Rescues Selective Autistic-Like Phenotypes
por: Mei, Yuan, et al.
Publicado: (2016)

Alteration of Fatty Acid Profile in Fragile X Syndrome
por: Abolghasemi, Armita, et al.
Publicado: (2022)

Autistic behavior in boys with fragile X syndrome: social approach and HPA-axis dysfunction
por: Roberts, Jane E., et al.
Publicado: (2009)

Munc13 Is a Molecular Target of Bryostatin 1
por: Blanco, Francisco A., et al.
Publicado: (2019)

Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features
por: Baker, Emma K., et al.
Publicado: (2019)

Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule
por: Hébert, Betty, et al.
Publicado: (2014)

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
por: Berry-Kravis, E, et al.
Publicado: (2009)

Gastrodin Rescues Autistic-Like Phenotypes in Valproic Acid-Induced Animal Model
por: Wang, Xiaona, et al.
Publicado: (2018)

Bryostatin-1: a promising compound for neurological disorders
por: Tian, Zhen, et al.
Publicado: (2023)

Sensory Processing Phenotypes in Fragile X Syndrome
por: Rais, Maham, et al.
Publicado: (2018)

A comparative study of autistic and non-autistic women’s experience of motherhood
por: Pohl, A. L., et al.
Publicado: (2020)

Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome
por: Li, Yue, et al.
Publicado: (2018)

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors
por: Thijsen, S F T, et al.
Publicado: (1999)

A phase II study of bryostatin 1 in metastatic malignant melanoma.
por: Propper, D. J., et al.
Publicado: (1998)

X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
por: Hall, Deborah A., et al.
Publicado: (2016)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
por: Prendiville, J., et al.
Publicado: (1993)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

Phorbol myristate acetate and Bryostatin 1 rescue IFN-gamma inducibility of MHC class II molecules in LS1034 colorectal carcinoma cell line
por: Kudinov, Yuri, et al.
Publicado: (2003)

Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014)

Synthesis of seco-B-Ring Bryostatin Analogue WN-1 via C–C Bond-Forming Hydrogenation: Critical Contribution of the B-Ring in Determining Bryostatin-like and Phorbol 12-Myristate 13-Acetate-like Properties
por: Andrews, Ian P., et al.
Publicado: (2014)

AAV‐delivered diacylglycerol kinase DGKk achieves long‐term rescue of fragile X syndrome mouse model
por: Habbas, Karima, et al.
Publicado: (2022)

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
por: Blackhall, F H, et al.
Publicado: (2001)

Treating a novel plasticity defect rescues episodic memory in Fragile X model mice
por: Wang, Weisheng, et al.
Publicado: (2017)

Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model
por: Lim, Chae-Seok, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3h2rp3ood7bm3mbge75erit206